PharmaCorp Rx Inc.
PCRX.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.54% | 110.79% | -81.73% | -55.99% | 493.89% |
| Total Receivables | 228.33% | 291.15% | 242.15% | 832.02% | -- |
| Inventory | 94.38% | 116.20% | 625.68% | 3,049.75% | -- |
| Prepaid Expenses | 200.89% | 76.65% | 183.23% | 168.83% | 3,100.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 91.17% | 115.21% | -69.93% | -45.35% | 561.20% |
|
|
|||||
| Total Current Assets | 91.17% | 115.21% | -69.93% | -45.35% | 561.20% |
| Net Property, Plant & Equipment | 40.65% | 42.91% | 351.09% | 399.55% | -- |
| Long-term Investments | 67.42% | 70.07% | 603.58% | 1,893.12% | -- |
| Goodwill | 67.42% | 70.07% | 603.58% | 1,893.12% | -- |
| Total Other Intangibles | 134.46% | 137.13% | 297.15% | 456.16% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 83.90% | 95.43% | 20.06% | 46.35% | 1,465.83% |
|
|
|||||
| Total Accounts Payable | 70.61% | 255.40% | 459.79% | 391.72% | 2,147.31% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 270.87% | 282.56% | 222.50% | 14.76% | -- |
| Total Finance Division Other Current Liabilities | -86.24% | 524.66% | -- | 123.53% | -- |
| Total Other Current Liabilities | -86.24% | 524.66% | -- | 123.53% | -- |
| Total Current Liabilities | 74.17% | 259.45% | 406.50% | 295.19% | 2,619.96% |
|
|
|||||
| Total Current Liabilities | 74.17% | 259.45% | 406.50% | 295.19% | 2,619.96% |
| Long-Term Debt | 958.67% | 918.58% | 805.21% | -20.88% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 91.58% | 97.07% | 30.72% | 9.09% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 67.80% | 70.89% | 327.80% | 471.28% | -- |
| Total Liabilities | 130.36% | 200.62% | 358.38% | 195.91% | 7,104.04% |
|
|
|||||
| Common Stock & APIC | 69.07% | 71.68% | -3.09% | 34.03% | 827.58% |
| Retained Earnings | -57.63% | -62.73% | 9.62% | -20.11% | -38.24% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 76.84% | 79.56% | -2.48% | 35.16% | 1,290.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 76.84% | 79.56% | -2.48% | 35.16% | 1,290.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 89.78% | 64.17% | -10.38% | 50.40% | -- |
| Total Equity | 76.94% | 79.45% | -2.55% | 35.26% | 1,301.48% |
|
|
|||||